Work

Supplementary Figure 2 from ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 95K, Supplementary Figure 2. The Chk1 inhibitor LY2603618 sensitizes OVCAR-8 and PEO1 cells to gemcitabine.

DOI: 10.1158/0008-5472.22396683.v1

Authors: Catherine J. Huntoon, Karen S. Flatten, Andrea E. Wahner Hendrickson, Amelia M. Huehls, Shari L. Sutor, Scott H. Kaufmann, Larry M. Karnitz

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361259307

Cites:

Cited by:

Related to: 10